The large conductance, Ca2+-activated K+ channels (BKCa, KCa1.1) are expressed in various brain neurons where they play important roles in regulating action potential duration, firing frequency and neurotransmitter release. Membrane potential depolarization and rising levels of intracellular Ca2+ gated BKCa channels, which in turn results in an outward K+ flux that re/hyperpolarizes the membrane. The sensitivity of BKCa channels to Ca2+ provides an important negative-feedback system for Ca2+ entry into brain neurons and suppresses repetitive firing. Thus, BKCa channel loss-of-function gives rise to neuronal hyperexcitability, which can lead to seizures. Evidence also indicates that BKCa channels can facilitate high-frequency firing (gain of function) in some brain neurons. Interestingly, both gain-of-function and loss-of-function mutations of genes encoding for various BKCa channel subunits have been associated with the development of neuronal excitability disorders, such as seizure disorders. The role of BKCa channels in the etiology of some neurological diseases raises the possibility that these channels can be used as molecular targets to prevent and suppress disease phenotypes.
Summary: Aims: Intracellular calcium plays an important role in neuronal hyperexcitability that leads to seizures. One calcium influx route of interest is the transient receptor potential vanilloid type 1 (TRPV1) channel. Here, we evaluated the effects of capsazepine (CPZ), a potent blocker ofTRPV1 channels on acoustically evoked seizures (audiogenic seizures,AGS) in the genetically epilepsy‐prone rat (GEPR‐3), a model of inherited epilepsy.Methods: Male and femaleGEPR‐3s were used. For the acuteCPZtreatment study,GEPR‐3s were tested forAGSsusceptibility before and after treatment with various doses ofCPZ(0, 1, 3, and 10 mg/kg; ip). For semichronicCPZtreatment study,GEPR‐3s were tested forAGSsusceptibility before and after 5‐dayCPZtreatment at the dose of 1 mg/kg (ip). The prevalence, latency, and severity ofAGSwere recorded and analyzed.Results: We found that acuteCPZpretreatment reduced the seizure severity in maleGEPR‐3s; the effect was dose‐dependent. In femaleGEPR‐3s, however,CPZtreatment completely suppressed the seizure susceptibility. Furthermore, semichronicCPZtreatment suppressed seizure susceptibility in femaleGEPR‐3s, but only reduced the seizure severity in maleGEPR‐3s.Conclusions: These findings suggest that theTRPV1 channel is a promising molecular target for seizure suppression, with femaleGEPR‐3s exhibiting higher sensitivity than maleGEPR‐3s.
2 January 2015 in International Journal of Neuropsychopharmacology
We previously reported increased current density through L-type voltage-gated Ca2+ (CaV1) channels in inferior colliculus (IC) neurons during alcohol withdrawal. However, the molecular correlate of this increased CaV1 current is currently unknown. Rats received three daily doses of ethanol every 8 hours for 4 consecutive days; control rats received vehicle. The IC was dissected at various time intervals following alcohol withdrawal, and the mRNA and protein levels of the CaV1.3 and CaV1.2 α1 subunits were measured. In separate experiments, rats were tested for their susceptibility to alcohol withdrawal–induced seizures (AWS) 3, 24, and 48 hours after alcohol withdrawal. In the alcohol-treated group, AWS were observed 24 hours after withdrawal; no seizures were observed at 3 or 48 hours. No seizures were observed at any time in the control-treated rats. Compared to control-treated rats, the mRNA level of the CaV1.3 α1 subunit was increased 1.4-fold, 1.9-fold, and 1.3-fold at 3, 24, and 48 hours, respectively. In contrast, the mRNA level of the CaV1.2 α1 subunit increased 1.5-fold and 1.4-fold at 24 and 48 hours, respectively. At 24 hours, Western blot analyses revealed that the levels of the CaV1.3 and CaV1.2 α1 subunits increased by 52% and 32%, respectively, 24 hours after alcohol withdrawal. In contrast, the CaV1.2 and CaV1.3 α1 subunits were not altered at either 3 or 48 hours during alcohol withdrawal. Expression of the CaV1.3 α1 subunit increased in parallel with AWS development, suggesting that altered L-type CaV1.3 channel expression is an important feature of AWS pathogenesis.